Journal
JOURNAL OF IMMUNOLOGICAL METHODS
Volume 424, Issue -, Pages 111-119Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jim.2015.05.009
Keywords
Listeriosis; Dendritic cells; Vaccines; Listeriolysin O; Glyceraldehyde-3-phosfate-dehydrogenase
Categories
Funding
- MINECO [SAF2009-08695, SAF2012-34203]
- National Institute of Allergy and Infectious Diseases, National Institutes of Health [HHSN272200800039C]
- [API2012/03/SAF2009-08695]
- [AIP2014/SAF2012-34203]
Ask authors/readers for more resources
Dendritic cells loaded with antigenic peptides, because of their safety and robust immune stimulation, would be ideal for induction of immunity to protect against listeriosis. However, there is no currently accepted method to predict which peptides derived from the Listeria proteome might confer protection. While elution of peptides from MI-IC molecules after Listeria infection yields high-affinity immune-dominant epitopes, these individual epitopes did not reliably confer Listeria protection. Instead we applied bioinformatic predictions of MHC class I and II epitopes to generate antigenic peptides that were then formulated with Advaxim, a novel polysaccharide particulate adjuvant able to enhance cross-presentation prior to being screened for their ability to induce protective T-cell responses. A combination of at least four intermediate strength MHC-I binding epitopes and one weak MIIC-II binding epitope when expressed in a single peptide sequence and formulated with Advax adjuvant induced.a potent T-cell response and high TNF-alpha and IL-12 production by dendritic cells resulting in robust listeriosis protection in susceptible mice. This T-cell vaccine approach might be useful for the design of vaccines to protect against listeriosis or other intracellular infections. (C) 2015 The Authors. Published by Elsevier B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available